Journal of Clinical Microbiology

• 

  Publication Venue For

  • Closing the Brief Case: The Fly Who Cried Wohlf..  60:e0108121. 2022
  • The Brief Case: The Fly Who Cried Wohlf..  60:e0107321. 2022
  • Activity of Amikacin against Isolates of Mycobacterium avium Complex with Proposed MIC Breakpoints and Finding of a 16S rRNA Gene Mutation in Treated Isolates..  52:1311-1311. 2014
  • Authors' reply.  46:1156. 2008
  • Detection of inducible clindamycin resistance in staphylococci by broth microdilution using erythromycin-clindamycin combination wells..  45:3954-3957. 2007
  • Detection of bloodstream infections in adults: how many blood cultures are needed?.  45:3546-3548. 2007
  • Use of peptide nucleic acid-fluorescence in situ hybridization for definitive, rapid identification of five common Candida species..  45:3802-3803. 2007
  • Yield of stool culture with isolate toxin testing versus a two-step algorithm including stool toxin testing for detection of toxigenic Clostridium difficile..  45:3601-3605. 2007
  • First contemporary case of human infection with Cryptococcus gattii in Puget Sound: evidence for spread of the Vancouver Island outbreak..  45:3086-3088. 2007
  • Quality control and reference guidelines for CLSI broth microdilution method (M38-A document) for susceptibility testing of anidulafungin against molds..  45:2180-2182. 2007
  • Comparison of the Digene Hybrid Capture System Cytomegalovirus (CMV) DNA (version 2.0), Roche CMV UL54 analyte-specific reagent, and QIAGEN RealArt CMV LightCycler PCR reagent tests using AcroMetrix OptiQuant CMV DNA quantification panels and specimens from allogeneic-stem-cell transplant recipients..  45:1972-1973. 2007
  • Genetic relatedness of Streptococcus pneumoniae isolates from paired blood and respiratory specimens..  45:2017-2019. 2007
  • Tigecycline disk diffusion breakpoints of Acinetobacter spp.: a clinical point of view..  45:2095. 2007
  • Reevaluation of Clinical and Laboratory Standards Institute disk diffusion breakpoints for tetracyclines for testing Enterobacteriaceae..  45:1640-1643. 2007
  • Controlled clinical comparison of BacT/ALERT standard aerobic and standard anaerobic blood culture bottles inoculated directly or after transport in sodium polyanethol sulfonate tubes..  45:1357-1359. 2007
  • Comparative evaluation of Etest and sensititre yeastone panels against the Clinical and Laboratory Standards Institute M27-A2 reference broth microdilution method for testing Candida susceptibility to seven antifungal agents..  45:698-706. 2007
  • Validation of laboratory screening criteria for herpes simplex virus testing of cerebrospinal fluid..  45:721-724. 2007
  • Burkholderia glumae infection in an infant with chronic granulomatous disease..  45:662-665. 2007
  • Controlled clinical comparison of VersaTREK and BacT/ALERT blood culture systems..  45:299-302. 2007
  • Plasmalyte as a cause of false-positive results for Aspergillus galactomannan in bronchoalveolar lavage fluid..  45:676-677. 2007
  • Multicenter studies of tigecycline disk diffusion susceptibility results for Acinetobacter spp..  45:227-230. 2007
  • Blood culture contamination in Tanzania, Malawi, and the United States: a microbiological tale of three cities..  44:4425-4429. 2006
  • Fatal granulomatous Acanthamoeba encephalitis mimicking a stroke, diagnosed by correlation of results of sequential magnetic resonance imaging, biopsy, in vitro culture, immunofluorescence analysis, and molecular analysis..  44:4265-4269. 2006
  • Performance of rapid streptococcal antigen testing varies by personnel..  44:3918-3922. 2006
  • Reverse transcription-PCR-enzyme-linked immunosorbent assay for rapid detection and differentiation of alphavirus infections..  44:4000-4008. 2006
  • Diagnosis of streptococcal pharyngitis by detection of Streptococcus pyogenes in posterior pharyngeal versus oral cavity specimens..  44:2593-2594. 2006
  • Unilateral empyema as a complication of infectious mononucleosis: a pathogenic variant of Lemierre's syndrome..  44:659-661. 2006
  • Utility of extended blood culture incubation for isolation of Haemophilus, Actinobacillus, Cardiobacterium, Eikenella, and Kingella organisms: a retrospective multicenter evaluation..  44:257-259. 2006
  • Validation of performance of plastic versus glass bottles for culturing anaerobes from blood in BacT/ALERT SN medium..  43:6150-6151. 2005
  • Quality control and reference guidelines for CLSI broth microdilution susceptibility method (M 38-A document) for amphotericin B, itraconazole, posaconazole, and voriconazole..  43:5243-5246. 2005
  • Reproducibility of low galactomannan enzyme immunoassay index values tested in multiple laboratories..  43:4796-4800. 2005
  • Spatial organization and composition of the mucosal flora in patients with inflammatory bowel disease..  43:3380-3389. 2005
  • Multicenter evaluation of a Candida albicans peptide nucleic acid fluorescent in situ hybridization probe for characterization of yeast isolates from blood cultures..  43:2909-2912. 2005
  • Selection of strains for quality assessment of the disk induction method for detection of inducible clindamycin resistance in Staphylococci: a CLSI collaborative study..  43:2613-2615. 2005
  • Streptococcus pneumoniae antigen test using positive blood culture bottles as an alternative method to diagnose pneumococcal bacteremia..  43:2510-2512. 2005
  • Controlled clinical comparison of plastic and glass bottles of BacT/ALERT FA medium for culturing organisms from blood of adult patients..  43:1960-1962. 2005
  • Erratum: Detection of Pneumocystis jiroveci in respiratory specimens by four staining methods (Journal of Clinical Microbiology (2004) 42:7 (3333-3335)).  43:2038. 2005
  • Comparative analysis of environmental and clinical populations of Cryptococcus neoformans..  43:556-564. 2005
  • Controlled clinical comparison of plastic versus glass bottles of BacT/ALERT PF medium for culturing blood from children..  43:445-447. 2005
  • Cryptococcus neoformans isolates from transplant recipients are not selected for resistance to calcineurin inhibitors by current immunosuppressive regimens..  43:464-467. 2005
  • Phylogeny and evolution of medical species of Candida and related taxa: a multigenic analysis..  42:5624-5635. 2004
  • Controlled clinical comparison of the BacT/ALERT FN and the standard anaerobic SN blood culture medium..  42:4581-4585. 2004
  • Interlaboratory comparison of results of susceptibility testing with caspofungin against Candida and Aspergillus species..  42:3475-3482. 2004
  • Multicenter evaluation of use of penicillin and ampicillin as surrogates for in vitro testing of susceptibility of enterococci to imipenem..  42:3747-3751. 2004
  • Detection of Pneumocystis jiroveci in respiratory specimens by four staining methods..  42:3333-3335. 2004
  • Molecular epidemiologic evaluation of endocarditis due to Oerskovia turbata and CDC group A-3 associated with contaminated homograft valves..  42:2495-2500. 2004
  • Aspergillus fumigatus empyema, arthritis, and calcaneal osteomyelitis in a lung transplant patient successfully treated with posaconazole..  42:1376-1378. 2004
  • Cryptococcus neoformans shows a remarkable genotypic diversity in Brazil..  42:1356-1359. 2004
  • Development, implementation, and impact of acceptability criteria for serologic tests for infectious diseases..  42:881-883. 2004
  • Risk of fungemia due to Rhodotorula and antifungal susceptibility testing of Rhodotorula isolates..  41:5233-5235. 2003
  • Scedosporium prolificans osteomyelitis in an immunocompetent child treated with voriconazole and caspofungin, as well as locally applied polyhexamethylene biguanide..  41:3981-3985. 2003
  • Comparison of microscan broth microdilution, synergy quad plate agar dilution, and disk diffusion screening methods for detection of high-level aminoglycoside resistance in enterococcus species..  41:2703-2705. 2003
  • Controlled clinical comparison of BacT/ALERT standard aerobic medium with BACTEC standard aerobic medium for culturing blood..  41:2391-2394. 2003
  • Characterization of Mycobacterium montefiorense sp. nov., a novel pathogenic Mycobacterium from moray eels that is related to Mycobacterium triplex..  41:2147-2152. 2003
  • Controlled comparison of BACTEC 13A, MYCO/F LYTIC, BacT/ALERT MB, and ISOLATOR 10 systems for detection of mycobacteremia..  41:1987-1990. 2003
  • Immunochromatographic test for rapid detection of Streptococcus pneumoniae in the nasopharynx..  41:2271. 2003
  • Sepsis, multiple organ failure, and death due to Pandoraea pnomenusa infection after lung transplantation..  41:2255-2257. 2003
  • Cost-effectiveness analysis of the gen-probe amplified mycobacterium tuberculosis direct test as used routinely on smear-positive respiratory specimens..  41:948-953. 2003
  • Identification of Histoplasma capsulatum from culture extracts by real-time PCR..  41:1295-1298. 2003
  • Evaluation of four commercially available rapid serologic tests for diagnosis of leptospirosis..  41:803-809. 2003
  • Rapid identification of pathogenic fungi directly from cultures by using multiplex PCR..  40:2860-2865. 2002
  • Assessment of the COBAS Amplicor HBV Monitor Test for quantitation of serum hepatitis B virus DNA levels..  40:1972-1976. 2002
  • Six-year molecular analysis of Burkholderia cepacia complex isolates among cystic fibrosis patients at a referral center for lung transplantation..  40:1188-1193. 2002
  • Identification of a p28 gene in Ehrlichia ewingii: evaluation of gene for use as a target for a species-specific PCR diagnostic assay..  39:3871-3876. 2001
  • Evaluation of a rapid immunochromatographic test for detection of Streptococcus pneumoniae antigen in urine samples from adults with community-acquired pneumonia..  39:3495-3498. 2001
  • Contamination of catheter-drawn blood cultures..  39:3393-3394. 2001
  • Evaluation of the Affirm Ambient Temperature Transport System for the detection and identification of Trichomonas vaginalis, Gardnerella vaginalis, and Candida species from vaginal fluid specimens..  39:3197-3199. 2001
  • Relevance of the number of positive bottles in determining clinical significance of coagulase-negative staphylococci in blood cultures..  39:3279-3281. 2001
  • Controlled comparison of original vented aerobic fan medium with new nonvented BacT/ALERT FA medium for culturing blood..  39:2098-2101. 2001
  • Development of an env gp41-based heteroduplex mobility assay for rapid human immunodeficiency virus type 1 subtyping..  39:2110-2114. 2001
  • Utility of paired BACTEC MYCO/F LYTIC blood culture vials for detection of bacteremia, mycobacteremia, and fungemia..  39:1960-1962. 2001
  • Controlled clinical comparison of BACTEC plus anaerobic/F to standard anaerobic/F as the anaerobic companion bottle to plus aerobic/F medium for culturing blood from adults..  39:983-989. 2001
  • Controlled comparison of BacT/ALERT FAN aerobic medium and BATEC fungal blood culture medium for detection of fungemia..  39:622-624. 2001
  • Bursitis due to Mycobacterium goodii, a recently described, rapidly growing mycobacterium..  39:404-405. 2001
  • Rapid identification of laboratory contamination with Mycobacterium tuberculosis using variable number tandem repeat analysis..  39:69-74. 2001
  • Validity of cultures of fluid collected through drainage catheters versus those obtained by direct aspiration..  39:66-68. 2001
  • Comparison of iodophor and alcohol pledgets with the Medi-Flex blood culture prep kit II for preventing contamination of blood cultures..  38:4665-4667. 2000
  • Comparison of BACTEC MYCO/F LYTIC and WAMPOLE ISOLATOR 10 (lysis-centrifugation) systems for detection of bacteremia, mycobacteremia, and fungemia in a developing country..  38:2994-2997. 2000
  • Development of a serological test for Haemophilus ducreyi for seroprevalence studies..  38:1520-1526. 2000
  • Clonal and spontaneous origins of fluconazole resistance in Candida albicans..  38:1214-1220. 2000
  • Comparison of blood collected in acid-citrate-dextrose and EDTA for use in human immunodeficiency virus peripheral blood mononuclear cell cultures..  38:858-860. 2000
  • Erratum: Epidemiological investigation of vaginal Saccharomyces cerevisiae isolates by a genotypic method (Journal of Clinical Microbiology (1998) 36:2 (557-562)).  38:1311. 2000
  • Species and genotypic diversities and similarities of pathogenic yeasts colonizing women..  37:3835-3843. 1999
  • Two sensitive PCR-based methods for detection of hepatitis B virus variants associated with reduced susceptibility to lamivudine..  37:3338-3347. 1999
  • Comparison of methods based on different molecular epidemiological markers for typing of Mycobacterium tuberculosis complex strains: interlaboratory study of discriminatory power and reproducibility..  37:2607-2618. 1999
  • Detection of phylogenetically diverse human immunodeficiency virus type 1 groups M and O from plasma by using highly sensitive and specific generic primers..  37:2581-2586. 1999
  • Controlled clinical comparison of bioMérieux VITAL and BACTEC NR-660 blood culture systems for detection of bacteremia and fungemia in adults..  37:1709-1713. 1999
  • Phenotypic and genotypic characterization of Mycobacterium africanum isolates from West Africa..  37:1921-1926. 1999
  • Species identification and virulence attributes of Saccharomyces boulardii (nom. inval.)..  36:2613-2617. 1998
  • Colony size can be used to determine the MIC of fluconazole for pathogenic yeasts..  36:2383-2385. 1998
  • Clinical importance of identifying coagulase-negative staphylococci isolated from blood cultures: evaluation of MicroScan Rapid and Dried Overnight Gram-Positive panels versus a conventional reference method..  36:2089-2092. 1998
  • Bile-esculin test for presumptive identification of enterococci and streptococci: effects of bile concentration, inoculation technique, and incubation time..  36:1135-1136. 1998
  • Intergenic transcribed spacer PCR ribotyping for differentiation of Saccharomyces species and interspecific hybrids..  36:1035-1038. 1998
  • Epidemiological investigation of vaginal Saccharomyces cerevisiae isolates by a genotypic method..  36:557-562. 1998
  • Clinical utility of broth cultures of cerebrospinal fluid from patients at risk for shunt infections..  35:3109-3111. 1997
  • Comparison of PCR, culture, and histopathology for diagnosis of tuberculous pericarditis..  35:3254-3257. 1997
  • Comparison of use of phenotypic and genotypic characteristics for identification of species of the anamorph genus Candida and related teleomorph yeast species..  35:3171-3180. 1997
  • Controlled comparison of bioMérieux VITAL and BACTEC NR-660 systems for detection of bacteremia and fungemia in pediatric patients..  35:2007-2012. 1997
  • Application of DNA typing methods and genetic analysis to epidemiology and taxonomy of Saccharomyces isolates..  35:1822-1828. 1997
  • Bartonella clarridgeiae, a newly recognized zoonotic pathogen causing inoculation papules, fever, and lymphadenopathy (cat scratch disease)..  35:1813-1818. 1997
  • PCR identification of Mycobacterium bovis BCG..  35:566-569. 1997
  • Controlled clinical laboratory comparison of BACTEC plus aerobic/F resin medium with BacT/Alert aerobic FAN medium for detection of bacteremia and fungemia..  35:53-58. 1997
  • Development of interpretive criteria and quality control limits for macrolide and clindamycin susceptibility testing of Streptococcus pneumoniae..  34:2679-2684. 1996
  • Clinical importance of increased sensitivity of BacT/Alert FAN aerobic and anaerobic blood culture bottles..  34:2180-2184. 1996
  • Analysis of genes coding for small-subunit rRNA sequences in studying phylogenetics of dematiaceous fungal pathogens..  34:2049-2050. 1996
  • Comparison of Isolator 1.5 and BACTEC NR660 aerobic 6A blood culture systems for detection of fungemia in children..  34:1877-1879. 1996
  • Contemporary testing for enteric pathogens: the potential for cost, time, and health care savings..  34:1776-1778. 1996
  • Duration of incubation of fungal cultures..  34:1583-1585. 1996
  • Fatal, disseminated Acremonium strictum infection in a neutropenic host..  34:1333-1336. 1996
  • Rapid identification of Candida species by DNA fingerprinting with PCR..  34:615-621. 1996
  • Cost and time savings following introduction of rejection criteria for clinical specimens..  34:355-357. 1996
  • Rejection criteria for endotracheal aspirates from pediatric patients..  34:352-354. 1996
  • Value of terminal subcultures for blood cultures monitored by BACTEC 9240..  34:234-235. 1996
  • Prolonged Bartonella bacteremia in cats associated with cat-scratch disease patients..  33:3245-3251. 1995
  • Molecular characterization and multilaboratory evaluation of Enterococcus faecalis ATCC 51299 for quality control of screening tests for vancomycin and high-level aminoglycoside resistance in enterococci..  33:3019-3021. 1995
  • Multilaboratory evaluation of screening methods for detection of high-level aminoglycoside resistance in enterococci. National Committee for Clinical Laboratory Standards Study Group on Enterococci..  33:3008-3018. 1995
  • Discrimination of Mycobacterium tuberculosis strains by PCR..  33:2801-2802. 1995
  • Controlled evaluation of BacT/alert standard anaerobic and FAN anaerobic blood culture bottles for the detection of bacteremia and fungemia..  33:2265-2270. 1995
  • Genetic variability of Bacillus anthracis and related species..  33:1847-1850. 1995
  • Rapid bacterial antigen detection is not clinically useful..  33:1486-1491. 1995
  • Analysis of genes coding for small-subunit rRNA sequences in studying phylogenetics of dematiaceous fungal pathogens..  33:1322-1326. 1995
  • Controlled evaluation of BacT/Alert standard aerobic and FAN aerobic blood culture bottles for detection of bacteremia and fungemia..  33:978-981. 1995
  • Differentiation of strains in Mycobacterium tuberculosis complex by DNA sequence polymorphisms, including rapid identification of M. bovis BCG..  33:840-844. 1995
  • Clinical impact of bacteria and fungi recovered only from broth cultures..  33:161-165. 1995
  • Endocarditis in a dog due to infection with a novel Bartonella subspecies..  33:154-160. 1995
  • Interpretive criteria and quality control parameters for testing bacterial susceptibility to the fluoroquinolone PD131628..  33:235-238. 1995
  • Preliminary study using species-specific oligonucleotide probe for rRNA of Bilophila wadsworthia..  32:2510-2513. 1994
  • Controlled evaluation of 5 versus 10 milliliters of blood cultured in aerobic BacT/Alert blood culture bottles..  32:2103-2106. 1994
  • First report of involvement of Nodulisporium species in human disease..  32:2301-2304. 1994
  • Comparison of commercial kits for detection of cryptococcal antigen..  32:1680-1684. 1994
  • Development of a standardized screening method for detection of vancomycin-resistant enterococci..  32:1700-1704. 1994
  • Extensive DNA sequence conservation throughout the Mycobacterium tuberculosis complex..  32:1639-1643. 1994
  • Persistence of Campylobacter fetus bacteremia associated with absence of opsonizing antibodies..  32:1718-1720. 1994
  • Unique oligonucleotide primers in PCR for identification of Cryptococcus neoformans..  32:253-255. 1994
  • Karyotyping of Cryptococcus neoformans as an epidemiological tool..  31:3305-3309. 1993
  • Hybridization probes for conventional DNA fingerprinting used as single primers in the polymerase chain reaction to distinguish strains of Cryptococcus neoformans..  31:2274-2280. 1993
  • Rejection criteria for endotracheal aspirates..  31:2555. 1993
  • Reliability of cord formation in BACTEC media for presumptive identification of mycobacteria..  31:2533-2534. 1993
  • Application of rejection criteria for stool cultures for bacterial enteric pathogens..  31:2233-2235. 1993
  • Rationale for selective use of anaerobic blood cultures..  31:2110-2113. 1993
  • Mycobacteria in stool specimens: the nonvalue of smears for predicting culture results..  31:1385-1387. 1993
  • Rejection criteria for endotracheal aspirates from adults..  31:1027-1029. 1993
  • Controlled comparison of the BACTEC high-blood-volume fungal medium, BACTEC Plus 26 aerobic blood culture bottle, and 10-milliliter isolator blood culture system for detection of fungemia and bacteremia..  31:865-871. 1993
  • Enzyme immunoassay for detection of human immunodeficiency virus-specific immunoglobulin A antibodies..  31:681-684. 1993
  • Application of rejection criteria for stool ovum and parasite examinations..  30:3213-3216. 1992
  • Detection of binding antibodies to native and recombinant human immunodeficiency virus type 1 envelope glycoproteins following recombinant gp160 immunization measured by flow cytometry and enzyme immunoassays. The AIDS Vaccine Clinical Trials Network..  30:2606-2612. 1992
  • Outer membrane protein subtypes of Haemophilus influenzae type b isolates causing invasive disease in Victoria, Australia, from 1988 to 1990..  30:1879-1881. 1992
  • Revision of standards for adjusting the cation content of Mueller-Hinton broth for testing susceptibility of Pseudomonas aeruginosa to aminoglycosides..  30:585-589. 1992
  • Controlled comparison of the BacT/Alert and BACTEC 660/730 nonradiometric blood culture systems..  30:323-329. 1992
  • Controlled evaluation of BACTEC PLUS 27 and Roche Septi-Chek anaerobic blood culture bottles..  30:63-66. 1992
  • Ehrlichia chaffeensis, a new species associated with human ehrlichiosis..  29:2838-2842. 1991
  • Isolation and characterization of an Ehrlichia sp. from a patient diagnosed with human ehrlichiosis..  29:2741-2745. 1991
  • Enteroinvasive Escherichia coli: a cause of bacteremia in patients with AIDS..  29:2675-2677. 1991
  • Controlled evaluation of BACTEC Plus 26 and Roche Septi-Chek aerobic blood culture bottles..  29:879-882. 1991
  • Spiral gradient endpoint method compared to standard agar dilution for susceptibility testing of anaerobic gram-negative bacilli..  29:975-979. 1991
  • Erratum: Amplification of bacterial 16S ribosomal DNA with polymerase chain reaction (J. Clin. Microbiol. Volume 28, No. 9, p. 1943).  29:666. 1991
  • Antifusion activity in sera from persons infected with human immunodeficiency virus type 1..  28:2608-2611. 1990
  • Amplification of bacterial 16S ribosomal DNA with polymerase chain reaction..  28:1942-1946. 1990
  • BacT/Alert: an automated colorimetric microbial detection system..  28:1608-1612. 1990
  • Effect of altered headspace atmosphere on yield and speed of detection of the Oxoid Signal blood culture system versus the BACTEC radiometric system..  28:795-797. 1990
  • Interpretive criteria and quality control limits for ceftibuten disk susceptibility tests. Collaborative Antimicrobial Susceptibility Testing Group..  28:605-607. 1990
  • Controlled comparison of a new Becton Dickinson agar slant blood culture system with Roche Septi-Chek for the detection of bacteremia and fungemia..  27:2637-2639. 1989
  • Probe directed at a segment of Rickettsia rickettsii rRNA amplified with polymerase chain reaction..  27:2692-2696. 1989
  • Comparative evaluation of radiometric tryptic soy broth versus radiometric tryptic soy broth with 10% sucrose for detection of bacteremia and fungemia in pediatric patients..  27:2448-2450. 1989
  • Rahnella aquatilis, an unusual gram-negative rod isolated from the bronchial washing of a patient with acquired immunodeficiency syndrome..  27:1671-1672. 1989
  • Diagnosis of Giardia lamblia infections by detection of parasite-specific antigens..  27:431-435. 1989
  • Effect of agitation and terminal subcultures on yield and speed of detection of the Oxoid Signal blood culture system versus the BACTEC radiometric system..  27:427-430. 1989
  • Species-specific oligonucleotide probes for rRNA of Clostridium difficile and related species..  26:2484-2488. 1988
  • Susceptibility testing of anaerobic bacteria..  26:1253-1256. 1988
  • Comparative evaluation of Oxoid Signal and BACTEC radiometric blood culture systems for the detection of bacteremia and fungemia..  26:962-964. 1988
  • Controlled evaluation of blood culture medium containing gelatin and V-factor-analog for detection of septicemia in children..  26:747-749. 1988
  • Evaluation of antiviral drugs and neutralizing antibodies to human immunodeficiency virus by a rapid and sensitive microtiter infection assay..  26:231-235. 1988
  • Characteristics and sites of infection of Eubacterium nodatum, Eubacterium timidum, Eubacterium brachy, and other asaccharolytic eubacteria..  25:1540-1545. 1987
  • Controlled evaluation of modified radiometric blood culture medium supplemented with gelatin for detection of bacteremia and fungemia..  25:1373-1375. 1987
  • Cryptosporidium species, a protean protozoan..  25:967-975. 1987
  • Controlled evaluation of the agar-slide and radiometric blood culture systems for the detection of bacteremia and fungemia..  23:221-225. 1986
  • Modified extraction procedure for gas-liquid chromatography applied to the identification of anaerobic bacteria..  23:392-394. 1986
  • Immunoblot analyses of Candida albicans-associated antigens and antibodies in human sera..  23:46-52. 1986
  • Clinical comparison of an agar slide blood culture bottle with tryptic soy broth and a conventional blood culture bottle with supplemented peptone broth..  21:815-818. 1985
  • Effect of sodium polyanetholesulfonate and gelatin on the recovery of Gardnerella vaginalis from blood culture media..  21:686-688. 1985
  • Bioluminescence screening for bacteriuria..  21:527-530. 1985
  • Controlled evaluation of Trypticase soy broth in agar slide and conventional blood culture systems..  21:626-629. 1985
  • Controlled evaluation of supplemented peptone and Bactec blood culture broths for the detection of bacteremia and fungemia..  21:531-534. 1985
  • Use of a sodium polyanetholesulfonate disk for the identification of Gardnerella vaginalis..  21:146-149. 1985
  • Efficiency of various bile salt preparations for stimulation of Clostridium difficile spore germination..  18:1017-1019. 1983
  • Evaluation of transport media for Campylobacter jejuni in human fecal specimens..  18:803-807. 1983
  • Comparison of methods for recovery of Clostridium difficile from an environmental surface..  18:348-352. 1983
  • Controlled evaluation of hypertonic sucrose medium at a 1:5 ratio of blood to broth for detection of bacteremia and fungemia in supplemented peptone broth..  17:1045-1049. 1983
  • Agglutination of Naegleria fowleri and Naegleria gruberi by antibodies in human serum..  17:576-581. 1983
  • Effect of atmosphere and duration of incubation on primary isolation of group A streptococci from throat cultures..  17:338-340. 1983
  • Controlled evaluation of hypertonic sucrose medium for detection of bacteremia and fungemia in supplemented peptone broth..  16:490-494. 1982
  • Controlled evaluation of the effect of atmosphere of incubation on detection of bacteremia and fungemia in supplemented peptone broth..  16:437-442. 1982
  • Fluorescent-antibody test for detection of Clostridium difficile in stool specimens..  16:464-468. 1982
  • Comparison of CampyPak II with standard 5% oxygen and candle jars for growth of Campylobacter jejuni from human feces..  16:291-294. 1982
  • Comparison of an enzyme-linked immunoassay and a quantitative indirect fluorescent-antibody test with the conventional indirect fluorescent-antibody test for detecting antibodies to Toxoplasma gondii..  16:341-344. 1982
  • Comparative evaluation of supplemented peptone broth with sodium polyanetholesulfonate and trypticase soy broth with sodium amylosulfate for detection of septicemia..  16:107-110. 1982
  • Comparison of acridine orange, methylene blue, and Gram stains for blood cultures..  15:562-566. 1982
  • Controlled evaluation of the volume of blood cultured in detection of bacteremia and fungemia..  15:558-561. 1982
  • Use of sodium taurocholate to enhance spore recovery on a medium selective for Clostridium difficile..  15:443-446. 1982
  • Comparison of atmospheres of incubation for primary isolation of Campylobacter fetus subsp. jejuni from animal specimens: 5% oxygen versus candle jar..  15:53-57. 1982
  • Dark-field microscopy of human feces for presumptive diagnosis of Campylobacter fetus subsp. jejuni enteritis..  15:61-63. 1982
  • Immunoradiometric assay for examination and quantitation of Brucella abortus-specific antibodies reactive with the antigen(s) used in the indirect hemolysis test..  14:415-426. 1981
  • Growth of nutritionally variant streptococci on common laboratory and 10 commercial blood culture media..  14:329-332. 1981
  • Comparison of acridine orange and Gram stains for detection of microorganisms in cerebrospinal fluid and other clinical specimens..  14:201-205. 1981
  • Neisseria gonorrhoeae strains inhibited by vancomycin in selective media and correlation with auxotype..  14:94-99. 1981
  • Quality control limits for ampicillin, carbenicillin, mezlocillin, and piperacillin disk diffusion susceptibility tests: a collaborative study..  14:67-72. 1981
  • Evaluation of transport and storage techniques for isolation of Campylobacter fetus subsp. jejuni from turkey cecal specimens..  13:438-443. 1981
  • Enriched brucella medium for storage and transport of cultures of Campylobacter fetus subsp. jejuni..  12:479-480. 1980
  • Isolation of Campylobacter fetus subsp. jejuni from migratory waterfowl..  12:406-408. 1980
  • Conditions for conducting the indirect hemolysis test for detection of antibodies to Brucella abortus..  11:402-408. 1980
  • Foodborne outbreak of shigellosis caused by an unusual Shigella strain..  11:337-339. 1980
  • Serotypes and penicillin susceptibility of pneumococci isolated from blood..  11:242-244. 1980
  • Comparison of direct and standard antimicrobial disk susceptibility testing for bacteria isolated from blood..  10:482-487. 1979
  • Evaluation of preservative fluid for urine collected for culture..  10:42-45. 1979
  • Use of colony pools for diagnosis of enterotoxigenic Escherichia coli diarrhea..  9:493-497. 1979
  • Comparison of four plating media for isolating Vibrio cholerae..  9:79-83. 1979
  • Solid-phase microtiter radioimmunoassay blocking test for detection of antibodies to Escherichia coli heat-labile enterotoxin..  9:60-64. 1979
  • Effects of storage in an anaerobic transport system on bacteria in known polymicrobial mixtures and in clinical specimens..  8:680-688. 1978
  • Enzyme-linked immunosorbent assay for detection of Escherichia coli heat-labile enterotoxin..  6:439-444. 1977
  • Contained indirect viable-cell membrane immunofluorescence microassay for surface antigen analysis of cells infected with hazardous viruses..  5:86-90. 1977
  • Laboratory investigation of diarrhea in travelers to Mexico: evaluation of methods for detecting enterotoxigenic Echerichia coli..  3:486-495. 1976
  • Diagnostic value of indirect hemagglutination in the seroepidemiology of Shigella infections..  3:143-148. 1976
  • Motility-indole-lysine medium for presumptive identification of enteric pathogens of Enterobacteriaceae..  2:247-252. 1975
  • Motility-indole-lysine-sulfide medium..  2:266-267. 1975